HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Victoria's Secret

This article was originally published in The Rose Sheet

Executive Summary

Beauty flagship store to open in New York City's SoHo district in 2001, Intimate Brands says. The centerpiece specialty door, which will carry the firm's full line of beauty care items including Dream Angels fragrances, Body by Victoria skin care and color cosmetics, will follow the new "Angels Design" layout incrementally being introduced in stores nationwide. The decor combines soft, subtle wall hues and original antique furniture with backlit, cut glass displays and tables. The new design was formally introduced at a Dec. 7 grand opening event of the Victoria's Secret Manhattan store at 67th and Broadway. The 18,000 sq. ft. "high-volume" space includes select best-selling beauty items in a mezzanine area

You may also be interested in...



Victoria's Secret Ongoing Store Redesigns To Generate $1.5 Bil.

Victoria's Secret is dedicating approximately $800 mil. over the next three years to the ongoing redesign of new and existing beauty and lingerie stores. The effort is expected to help realize incremental sales of about $1.5 bil., the Intimate Brands subsidiary estimated.

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS008755

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel